Highlights From the 20 Most Popular Stocks Among Financial Advisors

Celgene Corporation (NASDAQ:CELG) recently presented the results of a Phase 3 study of the addition of bortezomib to REVLIMID in myeloma therapy, which showed higher remission rates and extended duration of disease control. Among the funds we track, Celgene Corporation (NASDAQ:CELG) also registered an increase in popularity, with 62 funds reporting stakes worth $2.05 billion in aggregate as of September 30, compared to 58 funds a quarter earlier. In this way, the funds we track have amassed 2.40% of Celgene Corporation (NASDAQ:CELG)’s outstanding stock.

Intrexon Corp (NYSE:XON), another entrant to the top 20 list, recently announced that it formed a joint venture with several external investors to produce 1,4-butandiol. Intrexon Energy Partners II will produce the chemical, used for the production of spandex, polyurethane, plastics and polyester, with the deal representing Intrexon’s second partnership that will utilize its gas-to-liquids bioconversion platform. During the third quarter, Intrexon Corp (NYSE:XON) registered an outflow of smart money capital, as 17 funds reported stakes with a total value of $205.51 million (equal to 5.90% of the company’s stock) as of the end of September, compared to 21 funds with stakes worth $387.43 million a quarter earlier. Billionaire Dan Loeb’s Third Point is among the largest shareholders of Intrexon in our database, holding 1.50 million shares of the company.

Below, you can find the full list of 20 stocks that were the most searched among financial advisors.

Disclosure: None